ScubaTx

About:

ScubaTx device will commercialise Persufflation, a tried-and-true but underutilised method of organ preservation.

Twitter/X: scubatx

Top Investors: Innovate UK, Praetura Ventures, GM&C Life Sciences Fund

Description:

ScubaTx device will commercialize Persufflation, a tried-and-true but underutilized method of organ preservation, by using industry-leading software design talents, deliver significant net savings to healthcare providers, enabling them to expand the supply of organs that can sustain life.

Total Funding Amount:

2.9M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom

Founded Date:

2020-01-01

Founders:

Leonardo Freitas, Stuart Kay, Toby Clark, William Scott

Number of Employees:

1-10

Last Funding Date:

2024-09-03

IPO Status:

Private

Industries: